Repository logo
 
Publication

Patient information leaflets of drugs used in cardiometabolic disorders: Suitability for use by older persons

dc.contributor.authorEspírito-Santo, Margarida
dc.contributor.authorPinto, Ezequiel
dc.contributor.authorEstêvão, M. Dulce
dc.contributor.authorNascimento, Tânia
dc.date.accessioned2024-02-27T09:48:24Z
dc.date.available2024-02-27T09:48:24Z
dc.date.issued2023-02-15
dc.date.updated2024-02-24T13:43:00Z
dc.description.abstractIn the European Union, all medicines must include appropriate labelling and the respective patient information leaflet (PIL), which is the most reachable source of medicine’s information for patients. This document includes a set of information understandable by their potential users and complementary to the information provided by health professionals. The ageing of the Portuguese population raises the need for the appropriateness of medicine’s information for older consumers, taking into account their specific needs arising from physiological changes impacting drug action. This project aimed to analyse the content of medicines’ PILs, specifically directed at older persons. A sample of medicines was selected considering the 100 active substances more consumed in Portugal by patients with chronic pathologies such as diabetes mellitus, hypertension, and dyslipidaemia. The analysis included readability, legibility, and content (directly and indirectly related to the use of medicines by older persons). A total of 69 PILs were analysed, and it was observed that the information provided about the drugs was included in most of these PILs (95.7%; n = 66) but without any specific information for patients belonging to different age groups. Signalling-specific warnings for older persons were only available in less than half of the PILs (46.4%; n = 32). The presence of relevant information on the appropriate use of the drug such as the recommended dose was only specified for older persons in 28% (n = 19) of the analysed PILs. The information available in PILs which can be considered as specifically directed to older persons is relatively scarce, even in areas as critical as the instructions for use. Hopefully, these results will contribute to increasing awareness regarding the need to adapt PILs’ content to specific consumers and to test them to guarantee that they are adequate for all potential consumers.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1159/000528664pt_PT
dc.identifier.eissn2504-3145
dc.identifier.slugcv-prod-3161271
dc.identifier.urihttp://hdl.handle.net/10400.1/20452
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherKarger Publisherspt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectConsumer health informationpt_PT
dc.subjectHealth literacypt_PT
dc.subjectMedicinespt_PT
dc.subjectOlder personspt_PT
dc.subjectPatient information leaflept_PT
dc.titlePatient information leaflets of drugs used in cardiometabolic disorders: Suitability for use by older personspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage18pt_PT
oaire.citation.startPage12pt_PT
oaire.citation.titlePortuguese Journal of Public Healthpt_PT
oaire.citation.volume41pt_PT
person.familyNameNeto Espírito-Santo
person.familyNamePinto
person.familyNameEstêvão
person.familyNameNascimento
person.givenNameMargarida de Fátima
person.givenNameEzequiel
person.givenNameMaria Dulce da Mota Antunes de Oliveira
person.givenNameTânia
person.identifierI-4695-2014
person.identifier2191220
person.identifier.ciencia-id6215-22B3-56BF
person.identifier.ciencia-id881B-53E8-0DB1
person.identifier.ciencia-id8F1D-1FFE-9777
person.identifier.orcid0000-0002-2200-0015
person.identifier.orcid0000-0001-9322-2937
person.identifier.orcid0000-0002-7151-8363
person.identifier.orcid0000-0003-2429-7374
person.identifier.scopus-author-id8381590400
person.identifier.scopus-author-id57150665300
rcaap.cv.cienciaid6215-22B3-56BF | Margarida de Fátima Neto Espírito-Santo
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication34f3dbba-01c4-4cb3-b3a9-f6d05fac2753
relation.isAuthorOfPublication9e56ecbb-6cca-45e4-ac9f-9a736c13d793
relation.isAuthorOfPublication67887883-2695-48cc-8221-aa46780ac143
relation.isAuthorOfPublicationf975caa2-7c09-4dca-ab01-23d4dcc587a2
relation.isAuthorOfPublication.latestForDiscovery9e56ecbb-6cca-45e4-ac9f-9a736c13d793

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Patient_Information_Leaflet_of_drugs_used_in_cardiometabolic_disorders.pdf
Size:
187.32 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.49 KB
Format:
Item-specific license agreed upon to submission
Description: